Fatty Liver (MASLD): Natural Support Options and What the Evidence Shows

MASLD (Metabolic-Associated Steatotic Liver Disease, formerly NAFLD) is the most prevalent liver condition in the world — affecting roughly 25–30% of adults globally, the majority of whom don’t know they have it.

There are currently no FDA-approved pharmaceutical treatments specifically for MASLD. Lifestyle modification is first-line. Supplements with evidence supporting liver health sit in the gap between “lifestyle changes” and “nothing else available.”

Here’s what has evidence, what doesn’t, and what to expect realistically.

Educational content. Not medical advice. MASLD management should involve a physician.

What You’re Actually Dealing With

MASLD is fat accumulation in the liver beyond 5% of liver weight, in the absence of significant alcohol use, driven by metabolic dysfunction — insulin resistance, metabolic syndrome, obesity, type 2 diabetes.

The spectrum:

Simple steatosis (fatty liver): Fat accumulation, minimal inflammation. Often reversible.
MASH (Metabolic-Associated Steatohepatitis): Steatosis + inflammation + hepatocyte damage. More serious.
Fibrosis: Scar tissue formation. Partially reversible in early stages.
Cirrhosis: Advanced fibrosis. Generally not reversible.

Most people with MASLD are at the steatosis or early MASH stage — the most reversible stages. The window for natural support and lifestyle intervention is widest here.

→ MASLD/NAFLD: Full Explainer →

First-Line: Lifestyle Changes With the Strongest Evidence

Weight loss: The single most evidence-backed intervention for MASLD. 5–10% body weight reduction improves liver histology. 10%+ weight loss produces significant fibrosis regression in most patients. No supplement approaches this effect size.

Exercise: Independent of weight loss, exercise reduces hepatic fat accumulation through AMPK activation and visceral fat reduction. 150 minutes/week moderate exercise is the evidence-based recommendation.

Mediterranean diet pattern: Reduces hepatic fat, inflammatory markers, and metabolic risk factors. Characterized by olive oil, fish, vegetables, legumes, limited refined carbohydrates and sugar.

Fructose reduction: Dramatically reducing sugar-sweetened beverages removes the primary dietary driver of hepatic de novo lipogenesis in MASLD patients.

These aren’t alternatives to supplements — they’re the foundation. Any supplement regimen for MASLD that doesn’t address these factors is working against headwinds.

Natural Supplements With Human Evidence for MASLD

DHM (Dihydromyricetin) — Tier 1

The 2026 MASLD RCT (Annals of Gastroenterology): 55 patients, 12 months, DHM 300mg/day. Results:

Significant reduction in ALT and GGT
Liver stiffness reduced from 6.3 → 5.3 kPa (p=0.001) — a clinically meaningful improvement
Zero adverse events

This is the most directly applicable human evidence in the supplement-for-MASLD category. Double-blind, placebo-controlled, 12 months, liver biomarker primary endpoints.

Mechanism: DHM’s anti-inflammatory activity (NF-κB and Kupffer cell modulation), antioxidant activity, and senolytic function (clearing senescent hepatic stellate cells that drive fibrosis) are all mechanistically relevant to MASLD pathology.

→ Full 2026 MASLD Study Breakdown →

Milk Thistle (Silymarin) — Tier 1

Multiple meta-analyses show consistent ALT and GGT reduction with silymarin supplementation in MASLD patients — typically 10–25% reductions from baseline. Cochrane review-level evidence for liver enzyme improvement.

Mechanism: Anti-inflammatory (NF-κB inhibition), antioxidant (direct ROS scavenging + glutathione upregulation), hepatocyte regeneration.

Important dose note: Clinical studies use 140–420mg standardized silymarin/day — not 140–420mg of raw milk thistle extract. Check the silymarin standardization percentage on the label.

Vitamin E — Tier 1 (With Caveats)

The PIVENS trial (NEJM, 2010) showed vitamin E 800 IU/day produced significant histological improvement in non-diabetic adult MASLD patients vs. placebo. This is one of the few interventions with randomized histological endpoint data in MASLD.

The caveats: The SELECT trial showed that vitamin E 400 IU/day increased prostate cancer risk in healthy men. Long-term high-dose vitamin E supplementation has a complicated risk picture. Not recommended without physician involvement.

Omega-3 Fatty Acids — Tier 2

Multiple RCTs show omega-3s (EPA/DHA, 2–4g/day) reduce liver fat in MASLD. Effect on fibrosis and inflammation endpoints is less consistent. Generally safe and beneficial for the metabolic risk factors driving MASLD.

What Doesn’t Have Evidence for MASLD

Detox teas and liver cleanses: No human evidence for any structural improvement in MASLD. The “liver cleanse” framework doesn’t map to the pathophysiology of fat accumulation.

Turmeric/curcumin: Interesting anti-inflammatory properties, very poor oral bioavailability without specialized formulations. Human MASLD evidence is preliminary and small.

Artichoke extract: Modest evidence for cholesterol reduction; MASLD-specific evidence is limited.

Activated charcoal: No mechanism for hepatic fat reduction or fibrosis regression. Not relevant.

The Realistic Timeline

MASLD develops over years of metabolic stress. Reversing hepatic fat accumulation takes weeks to months with consistent lifestyle change. Fibrosis regression, where possible, takes 6–12+ months.

The 2026 DHM trial saw significant liver stiffness improvement over 12 months of daily supplementation. Milk thistle meta-analyses show enzyme improvements over 8–24 weeks.

Supplement support for MASLD is a sustained commitment, not a 2-week protocol. And it works in the context of metabolic improvements, not instead of them.

When to See a Doctor

If you have:

Persistently elevated ALT or GGT on bloodwork
Suspected MASLD based on imaging
Right upper quadrant discomfort
Unexplained fatigue

…these warrant physician evaluation, not supplement optimization. The natural support options discussed here are appropriate for people with diagnosed mild MASLD working with a physician, or for people with metabolic risk factors taking preventive measures.

→ MASLD/NAFLD: Full Guide → → Liver Enzymes: What Your Numbers Mean → → Daily Habits for Liver Health →

Hovenia is a Canadian liver health supplement company. Products support liver health and wellness — not intended to diagnose, treat, cure, or prevent any disease. This statement has not been evaluated by the FDA or Health Canada.